Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical ...
FDA assessed data from 12 cancer types, considering sensitivity, specificity and cancer-signal origin; the program aims to ...
John Fairbanks was diagnosed with AL-Amyloidsis, new treatment retrains cells to fight the disease.
NSCLC development advances after FDA Breakthrough Therapy Designation for previously treated EGFR wild-type, c-Met disease.
Innovation in life sciences is accelerating, but so are the risks and complexities surrounding it. The companies that succeed will be those that can identify critical dependencies, build resilience ...
"Rocky" franchise star Dolph Lundgren was considering ending his life after a years-long battle with kidney cancer. Then a doctor "saved" his life by discovering a misdiagnosis had led to ineffective ...
Reinsurance Group of America upgraded to Buy after strong underwriting and investment returns. See here for a detailed ...
The In.Pact BTK is slated for a pivotal trial of about 400 people with peripheral artery disease in the lower legs facing ...
Developed by United States pharmaceutical company Gilead Sciences, the injectable drug can be used to prevent HIV. “It’s the most innovative tool that has reached the HIV arena for the last decade, ...
As long as I can still communicate, I will keep fighting for more research funding to find a cure. That’s why I’m voting yes on Proposition 38, the California Immunology Medical Research and Cures ...
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
Daraxonrasib, a drug developed by Dana-Farber Cancer Institute, works by blocking the specific gene mutations thought to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results